David Tuller

Trial By Error: What is Recovery Norway’s Role in the JAMA Network Open Study of Long Covid in Young People?

By David Tuller, DrPH*April is crowdfunding month at UC Berkeley. If you like my work, consider making a tax-deductible donation to Berkeley’s School of Public Health to support the Trial By Error project:  https://crowdfund.berkeley.edu/project/37217 As I wrote earlier this week, a new study of adolescents and young adults from Norway, ...

Trial By Error: New JAMA Article Seeks to Revive the Zombie Case Definition for CFS from 1994

By David Tuller, DrPH The long Covid narrative seems to bounce back and forth with each new study or review documenting contrasting findings—evidence of serious pathophysiological anomalies among sub-sets of patients followed by data that appear to implicate psychological and/or emotional factors in the generation of reported symptoms. A new ...

Trial By Error: Why Are Exercise Studies for Long Covid Still Failing to Address PEM Adequately?

By David Tuller, DrPHNote: I posted this on March 29th, and for some reason it disappeared from the site--so I am reposting it today. I have written previously about the issue of exercise studies for long Covid patients. As with the discredited PACE trial for the illness or cluster of ...

Trial By Error: An Update on the Missing Ethics Corrections in Multiple Esther Crawley Papers

By David Tuller, DrPHIn 2019, the University of Bristol and the UK's Health Research Authority issued a report about their joint investigation of 11 papers. The lead investigator of all 11 papers was Professor Esther Crawley, Bristol's methodologically and ethically challenged pediatrician and grant queen. The report recommended that Professor ...

Trial By Error: What the Hell is Going on with Cochrane’s Long-Delayed Re-Review of “Exercise Therapies”?

By David Tuller, DrPH What is going on with Cochrane’s much-delayed re-review of exercise therapy for the illness the organization is these days calling ME/CFS? It is more than three years since Cochrane announced plans to develop this completely new review, but no one outside the organization seems to have ...
Scroll to Top